End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,14,700 KRW | +3.71% | +2.59% | -8.61% |
20/05 | Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval | CI |
16/05 | GC Biopharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Past dividends on GC Biopharma Corp.
27/12/2023 | Annual 1500 KRW |
28/12/2022 | Annual 1750 KRW |
29/12/2021 | Annual 2000 KRW |
29/12/2020 | Annual 1500 KRW |
27/12/2019 | Annual 1000 KRW |
27/12/2018 | Annual 1000 KRW |
27/12/2017 | Annual 1250 KRW |
28/12/2016 | Annual 1250 KRW |
29/12/2015 | Annual 1750 KRW |
29/12/2014 | Annual 1250 KRW |
27/12/2013 | Annual 1250 KRW |
27/12/2012 | Annual 1250 KRW |
28/12/2011 | Annual 1500 KRW |
29/12/2010 | Annual 1750 KRW |
29/12/2009 | Annual 1250 KRW |
29/12/2008 | Annual 1000 KRW |
27/12/2007 | Annual 1000 KRW |
27/12/2006 | Annual 750 KRW |
28/12/2005 | Annual 500 KRW |
03/01/1996 | Annual 250 KRW |
03/01/1995 | Annual 250 KRW |
04/01/1993 | Annual 50 KRW |
- Stock Market
- Equities
- A006280 Stock
- Charts GC Biopharma Corp.
- Total Return chart